UniProt ID | EDF1_HUMAN | |
---|---|---|
UniProt AC | O60869 | |
Protein Name | Endothelial differentiation-related factor 1 | |
Gene Name | EDF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 148 | |
Subcellular Localization | Cytoplasm. Nucleus. Also nuclear upon binding to NR5A1 and treatment of cells with TPA or forskolin. | |
Protein Description | Transcriptional coactivator stimulating NR5A1 and ligand-dependent NR1H3/LXRA and PPARG transcriptional activities. Enhances the DNA-binding activity of ATF1, ATF2, CREB1 and NR5A1. Regulates nitric oxid synthase activity probably by sequestering calmodulin in the cytoplasm. May function in endothelial cells differentiation, hormone-induced cardiomyocytes hypertrophy and lipid metabolism.. | |
Protein Sequence | MAESDWDTVTVLRKKGPTAAQAKSKQAILAAQRRGEDVETSKKWAAGQNKQHSITKNTAKLDRETEELHHDRVTLEVGKVIQQGRQSKGLTQKDLATKINEKPQVIADYESGRAIPNNQVLGKIERAIGLKLRGKDIGKPIEKGPRAK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAESDWDTV ------CCCCCCCCC | 25.63 | 22223895 | |
4 (in isoform 2) | Phosphorylation | - | 34.17 | - | |
4 | Phosphorylation | ----MAESDWDTVTV ----CCCCCCCCCHH | 34.17 | 25159151 | |
8 | Phosphorylation | MAESDWDTVTVLRKK CCCCCCCCCHHHHHH | 17.52 | 22496350 | |
10 | Phosphorylation | ESDWDTVTVLRKKGP CCCCCCCHHHHHHCC | 18.86 | 29514088 | |
13 | Methylation | WDTVTVLRKKGPTAA CCCCHHHHHHCCCHH | 34.01 | - | |
15 | Ubiquitination | TVTVLRKKGPTAAQA CCHHHHHHCCCHHHH | 64.78 | 24816145 | |
23 | Ubiquitination | GPTAAQAKSKQAILA CCCHHHHHHHHHHHH | 46.21 | 29967540 | |
25 | Ubiquitination | TAAQAKSKQAILAAQ CHHHHHHHHHHHHHH | 42.94 | 32015554 | |
25 | 2-Hydroxyisobutyrylation | TAAQAKSKQAILAAQ CHHHHHHHHHHHHHH | 42.94 | - | |
25 | Methylation | TAAQAKSKQAILAAQ CHHHHHHHHHHHHHH | 42.94 | 24129315 | |
25 | Malonylation | TAAQAKSKQAILAAQ CHHHHHHHHHHHHHH | 42.94 | 26320211 | |
40 | Phosphorylation | RRGEDVETSKKWAAG HCCCCHHHHHHHHCC | 45.77 | 26074081 | |
41 | Phosphorylation | RGEDVETSKKWAAGQ CCCCHHHHHHHHCCC | 20.80 | 26074081 | |
42 | Ubiquitination | GEDVETSKKWAAGQN CCCHHHHHHHHCCCC | 60.81 | 33845483 | |
42 | Acetylation | GEDVETSKKWAAGQN CCCHHHHHHHHCCCC | 60.81 | 30588345 | |
50 | 2-Hydroxyisobutyrylation | KWAAGQNKQHSITKN HHHCCCCCCCCCCCC | 41.31 | - | |
50 | Ubiquitination | KWAAGQNKQHSITKN HHHCCCCCCCCCCCC | 41.31 | 29967540 | |
50 | Acetylation | KWAAGQNKQHSITKN HHHCCCCCCCCCCCC | 41.31 | 25953088 | |
53 (in isoform 2) | Phosphorylation | - | 29.47 | - | |
53 | Phosphorylation | AGQNKQHSITKNTAK CCCCCCCCCCCCCHH | 29.47 | 28674151 | |
55 | Phosphorylation | QNKQHSITKNTAKLD CCCCCCCCCCCHHCC | 22.66 | 20068231 | |
58 | Phosphorylation | QHSITKNTAKLDRET CCCCCCCCHHCCHHH | 27.07 | 26074081 | |
60 | Acetylation | SITKNTAKLDRETEE CCCCCCHHCCHHHHH | 49.21 | 25953088 | |
65 | Phosphorylation | TAKLDRETEELHHDR CHHCCHHHHHHCCCC | 35.34 | 28555341 | |
72 | Methylation | TEELHHDRVTLEVGK HHHHCCCCCHHHHHH | 20.97 | - | |
74 (in isoform 2) | Phosphorylation | - | 20.35 | - | |
74 | Phosphorylation | ELHHDRVTLEVGKVI HHCCCCCHHHHHHHH | 20.35 | 20068231 | |
79 | Ubiquitination | RVTLEVGKVIQQGRQ CCHHHHHHHHHHHHH | 41.14 | 23000965 | |
79 | Acetylation | RVTLEVGKVIQQGRQ CCHHHHHHHHHHHHH | 41.14 | 26051181 | |
81 | Ubiquitination | TLEVGKVIQQGRQSK HHHHHHHHHHHHHCC | 2.63 | 20972266 | |
84 | Ubiquitination | VGKVIQQGRQSKGLT HHHHHHHHHHCCCCC | 17.14 | 20972266 | |
91 | Phosphorylation | GRQSKGLTQKDLATK HHHCCCCCHHHHHHH | 42.09 | 10816571 | |
91 (in isoform 2) | Phosphorylation | - | 42.09 | - | |
93 | Malonylation | QSKGLTQKDLATKIN HCCCCCHHHHHHHHC | 49.85 | 26320211 | |
93 | Ubiquitination | QSKGLTQKDLATKIN HCCCCCHHHHHHHHC | 49.85 | 33845483 | |
93 | Acetylation | QSKGLTQKDLATKIN HCCCCCHHHHHHHHC | 49.85 | 23749302 | |
97 | Phosphorylation | LTQKDLATKINEKPQ CCHHHHHHHHCCCCC | 39.49 | 24719451 | |
98 | Acetylation | TQKDLATKINEKPQV CHHHHHHHHCCCCCE | 37.62 | 25953088 | |
98 | 2-Hydroxyisobutyrylation | TQKDLATKINEKPQV CHHHHHHHHCCCCCE | 37.62 | - | |
98 | Malonylation | TQKDLATKINEKPQV CHHHHHHHHCCCCCE | 37.62 | 26320211 | |
98 | Ubiquitination | TQKDLATKINEKPQV CHHHHHHHHCCCCCE | 37.62 | 22817900 | |
102 (in isoform 1) | Ubiquitination | - | 35.94 | 21890473 | |
102 | 2-Hydroxyisobutyrylation | LATKINEKPQVIADY HHHHHCCCCCEEEEC | 35.94 | - | |
102 (in isoform 2) | Ubiquitination | - | 35.94 | 21906983 | |
102 | Ubiquitination | LATKINEKPQVIADY HHHHHCCCCCEEEEC | 35.94 | 22817900 | |
102 | Acetylation | LATKINEKPQVIADY HHHHHCCCCCEEEEC | 35.94 | 26051181 | |
105 | Acetylation | KINEKPQVIADYESG HHCCCCCEEEECCCC | 5.45 | 19608861 | |
105 | Ubiquitination | KINEKPQVIADYESG HHCCCCCEEEECCCC | 5.45 | 32015554 | |
109 | Phosphorylation | KPQVIADYESGRAIP CCCEEEECCCCCCCC | 11.72 | 28796482 | |
111 | Phosphorylation | QVIADYESGRAIPNN CEEEECCCCCCCCCC | 27.61 | 28796482 | |
114 | Ubiquitination | ADYESGRAIPNNQVL EECCCCCCCCCCCHH | 25.72 | 24816145 | |
117 | Ubiquitination | ESGRAIPNNQVLGKI CCCCCCCCCCHHHHH | 45.51 | 24816145 | |
118 | Ubiquitination | SGRAIPNNQVLGKIE CCCCCCCCCHHHHHH | 28.16 | 23000965 | |
121 | Ubiquitination | AIPNNQVLGKIERAI CCCCCCHHHHHHHHH | 4.10 | 23000965 | |
122 | Ubiquitination | IPNNQVLGKIERAIG CCCCCHHHHHHHHHC | 30.00 | 23000965 | |
123 | Acetylation | PNNQVLGKIERAIGL CCCCHHHHHHHHHCC | 36.91 | 23954790 | |
123 | Ubiquitination | PNNQVLGKIERAIGL CCCCHHHHHHHHHCC | 36.91 | 32015554 | |
123 (in isoform 2) | Acetylation | - | 36.91 | - | |
125 | Ubiquitination | NQVLGKIERAIGLKL CCHHHHHHHHHCCEE | 39.27 | 23000965 | |
127 | Ubiquitination | VLGKIERAIGLKLRG HHHHHHHHHCCEECC | 6.34 | 23000965 | |
130 | Ubiquitination | KIERAIGLKLRGKDI HHHHHHCCEECCCCC | 3.74 | 23000965 | |
131 | Acetylation | IERAIGLKLRGKDIG HHHHHCCEECCCCCC | 30.81 | 25953088 | |
131 | Ubiquitination | IERAIGLKLRGKDIG HHHHHCCEECCCCCC | 30.81 | - | |
131 | Malonylation | IERAIGLKLRGKDIG HHHHHCCEECCCCCC | 30.81 | 26320211 | |
135 | Ubiquitination | IGLKLRGKDIGKPIE HCCEECCCCCCCCCC | 39.47 | 24816145 | |
135 | Acetylation | IGLKLRGKDIGKPIE HCCEECCCCCCCCCC | 39.47 | 26051181 | |
139 | Ubiquitination | LRGKDIGKPIEKGPR ECCCCCCCCCCCCCC | 43.06 | 23000965 | |
143 (in isoform 1) | Ubiquitination | - | 74.96 | 21890473 | |
143 | Acetylation | DIGKPIEKGPRAK-- CCCCCCCCCCCCC-- | 74.96 | 25953088 | |
143 | Ubiquitination | DIGKPIEKGPRAK-- CCCCCCCCCCCCC-- | 74.96 | 23000965 | |
148 | Ubiquitination | IEKGPRAK------- CCCCCCCC------- | 63.25 | 23000965 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EDF1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EDF1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EDF1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NR5A2_HUMAN | NR5A2 | physical | 12040021 | |
NR1H3_HUMAN | NR1H3 | physical | 12040021 | |
PPARG_HUMAN | PPARG | physical | 12040021 | |
RXRA_HUMAN | RXRA | physical | 12040021 | |
TBP_HUMAN | TBP | physical | 12040021 | |
TBP_HUMAN | TBP | physical | 10816571 | |
TBP_HUMAN | TBP | physical | 10567391 | |
STF1_HUMAN | NR5A1 | physical | 10567391 | |
NRL_HUMAN | NRL | physical | 16880509 | |
JUN_HUMAN | JUN | physical | 16880509 | |
CEBPA_HUMAN | CEBPA | physical | 16880509 | |
IDH3G_HUMAN | IDH3G | physical | 22939629 | |
DNJB1_HUMAN | DNAJB1 | physical | 26344197 | |
HNRPF_HUMAN | HNRNPF | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-4, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-123, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-4, AND MASS SPECTROMETRY. |